NCT03086863

Brief Summary

This is a multicenter, randomized, sham-controlled, patient- and assessor-blinded, and parallel trial to explore the effectiveness and safety of electroacupuncture (EA) therapy, compared with sham EA, for poststroke shoulder pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2017

Completed
24 days until next milestone

First Posted

Study publicly available on registry

March 22, 2017

Completed
12 days until next milestone

Study Start

First participant enrolled

April 3, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2017

Completed
Last Updated

December 2, 2017

Status Verified

November 1, 2017

Enrollment Period

8 months

First QC Date

February 26, 2017

Last Update Submit

November 30, 2017

Conditions

Keywords

electroacupuncturerandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Mean difference of visual analogue scale (VAS) between baseline and endpoint

    VAS is a patient-rated outcome with a 10-cm line representing 'not painful at all' for zero and 'most painful' for ten. Patient marks x on the line by oneself, based on how intense he/she thinks the pain is and assessor measures the length from zero point to x mark, which is the pain score.

    3 weeks

Secondary Outcomes (9)

  • before-after change of visual analogue scale (VAS) (intragroup effect)

    1~3 weeks

  • Mean difference of pain rating scale (PRS) between baseline and endpoint

    3 weeks

  • Mean difference of Fugl-Meyer assessment - upper extremity (FMA-UE) between baseline and endpoint

    3 weeks

  • Mean difference of passive ranges of motion (PROM) between baseline and endpoint

    3 weeks

  • Mean difference of manual muscle test (MMT) between baseline and endpoint

    3 weeks

  • +4 more secondary outcomes

Other Outcomes (1)

  • new Blinding index (BI)

    3 weeks (only at the end of the study)

Study Arms (2)

verum electroacupuncture

EXPERIMENTAL

* Electroacupuncture on LI4, LI15, TE14, SI9, SI11, and GB21, unilaterally * Needle insertion by 10-15 mm and de qi sensation * Park sham guide tubes * Low frequency electronic stimulation (30 Hz) * Retention for 20 minutes.

Device: electroacupuncture

sham electroacupuncture

SHAM COMPARATOR

* Park sham device on on LI4, LI15, TE14, SI9, SI11, and GB21, unilaterally * Needle installation without penetration * Park sham guide tubes * Low frequency electronic stimulation (30 Hz) for a fake noise without conduction * Retention for 20 minutes.

Device: sham electroacupuncture

Interventions

All the patients in verum electroacupuncture group will receive acupuncture on the six adjacent acupoints (LI4, LI15, TE14, SI9, SI11, and GB21) in unilateral side. Acupuncture needles (stainless steel, 0.25 mm × 40 mm, Dong Bang Acupuncture Inc., Republic of Korea) will be inserted 10-15 mm in depth and de qi sensation will be elicited. Park sham guide tubes will be used in verum group, too. Low frequency stimulate (STN-111, Stratek, Republic of Korea) will be connected to the tips of needles to provide electrical stimulation at middle frequency (30 Hz). Needles with electrical stimulation will be retained for 20 minutes. Patients should take this procedure 3 times a week for 3 weeks (9 sessions in total).

Also known as: verum EA
verum electroacupuncture

We selected a non-penetrating sham needling, i.e., Park sham device, which has been developed and validated in preceding studies as comparison. On the exactly same 6 acupoints as verum electroacupuncture group, needles will be installed with Park sham guide tubes and the same electrical stimulators will be connected the tips of needles. Since the needles do not penetrate the skin, the stimulation is not electrically conducted. To be sure of patient blinding, the low frequency stimulate will be turned on with the same frequency (30 Hz), which makes a fake noise, resulting in letting patients believe that they are taking real electroacupuncture therapy for 20 minutes. Sham group will also 9 session for 3 weeks (3 sessions a week).

Also known as: sham EA
sham electroacupuncture

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with cerebral hemorrhage or infarction examined by computed tomography (CT) magnetic resonance imaging (MRI) at least 2 weeks or more ago;
  • complaining hemiplegic shoulder pain of VAS ≥4;
  • agreeing that any treatments, including analgesics, for hemiplegic shoulder pain will not be changed from the previous 2 weeks prior to the enrollment until the last evaluation, if applicable;
  • fully explained about the clinical research and sign the informed consents.

You may not qualify if:

  • disorders, traumatic injury, or surgery of shoulders even before their stroke;
  • pacemakers, embedded neural stimulator, cardiac arrhythmia, epilepsy, peripheral neural injury on their medical history;
  • psychiatric disorders;
  • cancer within the past 5 years, regardless of its prognosis and location;
  • cognitive impairment that interferes with clinical assessment;
  • hypersensitivity or fears to acupuncture;
  • bleeding disorders (e.g. hemophilia or von Willebrand disease, etc.),
  • pregnancy,
  • difficulty in communicating with researchers, or
  • any other conditions who are considered inappropriate for participating in the trial by experienced practitioners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyung Hee University Korean Medicine Hospital

Seoul, 156-853, South Korea

Location

Related Publications (13)

  • Lee SH, Lim SM. Acupuncture for Poststroke Shoulder Pain: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:3549878. doi: 10.1155/2016/3549878. Epub 2016 Jul 31.

    PMID: 27547224BACKGROUND
  • Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials. 2004 Apr;25(2):143-56. doi: 10.1016/j.cct.2003.10.016.

    PMID: 15020033BACKGROUND
  • Park J, White A, Stevinson C, Ernst E, James M. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2002 Dec;20(4):168-74. doi: 10.1136/aim.20.4.168.

    PMID: 12512790BACKGROUND
  • Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56. doi: 10.1016/0304-3959(83)90126-4.

    PMID: 6226917BACKGROUND
  • Kim C, Kim C, Chun SI. Clinical value of a new self assessment method of pain. Journal of Korean Acamedy of Rehabilitation Medicine 22(2):305-311, 1998. (Korean)

    BACKGROUND
  • Kim HS, Her JG, Ko JY, Park DS, Woo JH, You YY, Choi YE. Reliability, concurrent validity, and responsiveness of the Fugl-Meyer assessment (FMA) for hemiplegic patients. Journal of Physical Therapy Science 24(9):893-899, 2012.

    BACKGROUND
  • Mendell JR, Florence J. Manual muscle testing. Muscle Nerve. 1990;13 Suppl:S16-20. doi: 10.1002/mus.880131307. No abstract available.

    PMID: 2233877BACKGROUND
  • Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil. 1999 Sep;80(9):1013-6. doi: 10.1016/s0003-9993(99)90053-9.

    PMID: 10489001BACKGROUND
  • Jung HY, Park BK, Shin HS, Kang YK, Pyun SB, Paik NJ, Kim SH, Kim TH, Han TR. Development of the Korean version of modified barthel index (K-MBI): multi-center study for subjects with Stroke. Journal of Korean Acamedy of Rehabilitation Medicine 31(3):283-297, 2007. (Korean)

    BACKGROUND
  • Rhee MK, Lee YH, Park SH, Sohn CH, Chung YC, Hong SK, Lee BK, Chang P, Yoon AR. A stadardization study of beck depression inventory Ⅰ - Korean version (K-BDI): reliability and factor analysis. The Korean Journal of Psychopathology 4(1):77-95, 1995. (Korean)

    BACKGROUND
  • Rhee MK, Lee YH, Jung HY, Chio JH, Kim SH, Kim YK, Lee SK. A stadardization study of beck depression inventory Ⅱ - Korean version (K-BDI): validity. The Korean Journal of Psychopathology 4(1):96-104, 1995 . (Korean)

    BACKGROUND
  • Wang KF, Zhang LJ, Lu F, Lu YH, Yang CH. Can Ashi points stimulation have specific effects on shoulder pain? A systematic review of randomized controlled trials. Chin J Integr Med. 2016 Jun;22(6):467-72. doi: 10.1007/s11655-015-2107-4. Epub 2015 Jun 30.

    PMID: 26129899BACKGROUND
  • Shin S, Yang SP, Yu A, Yoo J, Lim SM, Lee E. Effectiveness and safety of electroacupuncture for poststroke patients with shoulder pain: study protocol for a double-center, randomized, patient- and assessor-blinded, sham-controlled, parallel, clinical trial. BMC Complement Altern Med. 2019 Mar 12;19(1):58. doi: 10.1186/s12906-019-2468-x.

MeSH Terms

Conditions

StrokeShoulder PainCerebral InfarctionCerebral Hemorrhage

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBrain InfarctionBrain IschemiaInfarctionIschemiaPathologic ProcessesNecrosisIntracranial HemorrhagesHemorrhage

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Officials

  • Euiji Lee, Ph.D.

    Kyunghee University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Ph.D. KMD.

Study Record Dates

First Submitted

February 26, 2017

First Posted

March 22, 2017

Study Start

April 3, 2017

Primary Completion

November 29, 2017

Study Completion

November 29, 2017

Last Updated

December 2, 2017

Record last verified: 2017-11

Locations